SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as community members speculate on a potential short squeeze, citing high short interest and technical breakouts despite limited volume. Investors remain divided, with some betting on a long-term turnaround led by leadership, while others express frustration over stagnant price action and lack of clear acquisition news.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending as investors position for a potential short squeeze ahead of its upcoming earnings report, fueled by high short interest, elevated borrow rates, and speculation surrounding strategic growth. The community remains deeply engaged in a 'diamond hands' strategy, actively discussing the potential for a parabolic move driven by a combination of technical setup and anticipation of positive results.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors debate the impact of ongoing share dilution against the company's aggressive Bitcoin acquisition strategy, while the community remains sharply divided between those anticipating a major breakout and those predicting a correction. Traders are actively monitoring technical support levels and the stock's sensitivity to broader Bitcoin volatility, with bullish sentiment fueled by institutional interest and persistent short-squeeze speculation.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is trending amid intense community debate over a recent private placement and exclusive license agreement, with traders actively monitoring the stock for potential short squeeze setups. While some bulls are encouraged by the clinical pipeline and partnership news, bears remain skeptical, citing concerns over dilution and the potential for a downward repricing.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing heightened volatility and intense retail debate as the market anticipates quarterly results, with community discourse centered on the company's capital burn, potential dilution, and the critical R2 SUV launch. Traders are actively weighing strong delivery growth and strategic partnerships against macro headwinds like European tariffs and the company's long-term path to profitability.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is experiencing extreme volatility driven by a massive short squeeze and retail investor fervor surrounding its low-float status. The community is sharply divided, with bulls celebrating the rapid climb and urging others to hold for triple-digit gains, while bears warn of a pump-and-dump scheme and an inevitable correction.

AIOS Tech, Inc. is an investment holding company, which engages in the provision of financing solutions to small- and mid-size enterprises. The company was founded on May 29, 2012 and is headquartered in Shanghai, China.

AIOS Tech Inc. - Ordinary Shares - Class A

AIOS Tech Inc.

AIOS is attracting intense speculative interest as traders track its low-float dynamics and recent technical patterns often associated with aggressive short-term volatility. While some community members are capitalizing on rapid momentum swings, others remain cautious of potential dilution risks and the stock's history of significant price fluctuations.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following a record-breaking fiscal quarter where the company outperformed top and bottom-line estimates and announced a significant share buyback, leading to active investor debate over the stock's future momentum. The community is heavily focused on the company's forward-looking guidance, leadership transition, and whether the shares can sustain their rally toward the $300 level despite ongoing global supply chain headwinds.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing significant downward pressure following the announcement of a former Nike executive as the incoming CEO, an appointment that has frustrated many investors who associate her previous leadership with lackluster performance and stagnant innovation. The community is deeply divided, with some critics viewing the hire as a sign of continued institutional mismanagement and cultural misalignment, while others see a potential long-term value play given the company's strong balance sheet and currently compressed valuation.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's Co (WEN) is currently a focal point for investors due to high short interest and anticipation surrounding a potential turnaround, management changes, or M&A activity. The community remains divided, with some highlighting the stock's oversold valuation and solid dividend as an attractive long-term play, while others express frustration over stagnant price action, the absence of a permanent CEO, and broader challenges within the fast-food sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence

Vanda Pharmaceuticals announces the publication of 'Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis' in NEJM Evidence Vanda Pharmaceuticals announces the publication of...

Arcus Biosciences, Inc. (RCUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Arcus Biosciences (RCUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AnaptysBio (NASDAQ:ANAB) Hits New 1-Year High - Time to Buy?

AnaptysBio (NASDAQ:ANAB) Sets New 1-Year High - What's Next...

AnaptysBio Stock Rallies As Delaware Court Tosses Tesaro Breach Claim

AnaptysBio shares jump 12% after a favorable Delaware Court ruling in the Tesaro dispute. See the latest technical outlook and more.read more...

AnaptysBio (NASDAQ:ANAB) Trading 11.2% Higher - Time to Buy?

AnaptysBio (NASDAQ:ANAB) Stock Price Up 11.2% - Here's What Happened...

AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

AnaptysBio (ANAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AnaptysBio (ANAB) Surges 14.8%: Is This an Indication of Further Gains?

AnaptysBio (ANAB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

AnaptysBio (ANAB) Expected to Announce Earnings on Monday

AnaptysBio (NASDAQ:ANAB) will be releasing its Q1 2026 earnings before the market opens on Monday, May 4. (View Earnings Report at...

AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of AnaptysBio, Inc. (NASDAQ:ANAB - Get Free Report) have received a consensus rating of "Moderate Buy" from the eleven research firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommen...

AnaptysBio (NASDAQ:ANAB) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised shares of AnaptysBio from a "buy" rating to a "strong-buy" rating in a research report on Saturday...

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.

ANAB
AnaptysBio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANAB News

ANABAnaptysBio Inc